Journal of Surgery Concepts & Practice ›› 2018, Vol. 23 ›› Issue (03): 289-292.doi: 10.16139/j.1007-9610.2018.03.021
• Review • Previous Articles
Received:2018-02-02
Published:2020-07-25
CLC Number:
| [1] Forner A, Llovet JM, Bruix J.Hepatocellular carcinoma[J]. Lancet,2012,379(9822):1245-1255. [2] Hanahan D, Weinberg RA.Hallmarks of cancer: the next generation[J]. Cell,2011,144(5):646-674. [3] Rinninella E, Cerrito L, Spinelli I, et al.Chemotherapy for hepatocellular carcinoma: current evidence and future perspectives[J]. J Clin Transl Hepatol,2017,5(3):235-248. [4] Marx J.Cancer research. Inflammation and cancer: the link grows stronger[J]. Science,2004,306(5698):966-968. [5] Prinz I, Silva-Santos B, Pennington DJ.Functional deve-lopment of γδ T cells[J]. Eur J Immunol,2013,43(8):1988-1994. [6] Philip M, Rowley DA, Schreiber H.Inflammation as a tumor promoter in cancer induction[J]. Semin Cancer Biol,2004,14(6):433-439. [7] Chien YH, Meyer C, Bonneville M.γδ T cells: first line of defense and beyond[J]. Annu Rev Immunol,2014,32:121-155. [8] Kabelitz D, Wesch D, He W.Perspectives of gammadelta T cells in tumor immunology[J]. Cancer Res,2007, 67(1):5-8 [9] Deng Y, Du Y, Zhang Q, et al.Human cytidine deaminases facilitate hepatitis B virus evolution and link inflammation and hepatocellular carcinoma[J]. Cancer Lett,2014,343(2):161-171. [10] Mantovani A, Allavena P, Sica A, et al.Cancer-related inflammation[J]. Nature,2008,454(7203):436-444. [11] Campillo JA, Martinez-Escribano JA, Minguela A, et al.Increased number of cytotoxic CD3+ CD28- gammadelta T cells in peripheral blood of patients with cutaneous malignant melanoma[J]. Dermatology,2007,214(4):283-288. [12] Patin EC, Soulard D, Fleury S, et al.Type Ⅰ IFN receptor signaling controls IL7-dependent accumulation and activi-ty of protumoral IL17A-producing γδ T cells in breast cancer[J]. Cancer Res,2018,78(1):195-204. [13] Wang X, Tian Z.γδ T cells in liver diseases[J]. Front Med,2018,12(3):262-268. [14] Hayday AC.γδ cells: a right time and a right place for a conserved third way of protection[J]. Annu Rev Immunol,2000,18:975-1026. [15] Albini A, Bruno A, Noonan DM, et al.Contribution to tumor angiogenesis from innate immune cells within the tumor microenvironment: implications for immunotherapy[J]. Front Immunol,2018,9:527. [16] Ribot JC, Serre K, Silva-Santos B.Developmental and functional assays to study murine and human γδ T cells[J]. Methods Mol Biol,2017,1514:257-267. [17] Cai XY, Wang JX, Yi Y, et al.Low counts of γδ T cells in peritumoral liver tissue are related to more frequent recurrence in patients with hepatocellular carcinoma after curative resection[J]. Asian Pac J Cancer Prev,2014,15(2):775-780. [18] Sugie T, Suzuki E, Yamauchi A, et al.Combined effects of neoadjuvant letrozole and zoledronic acid on γδT cells in postmenopausal women with early-stage breast cancer[J]. Breast,2018,38:114-119. [19] 陈复兴, 刘军权, 冯霞, 等. 人末梢血γδT细胞对消化系统肿瘤细胞的杀伤作用[J]. 世界华人消化杂志,2007,15(14):1591-1595. [20] Wakita D, Sumida K, Iwakura Y, et al.Tumor-infiltrating IL-17-producing γδ T cells support the progression of tumor by promoting angiogenesis[J]. Eur J Immunol,2010;40(7):1927-1937. [21] Ma S, Cheng Q, Cai Y, et al.IL-17A produced by γδ T cells promotes tumor growth in hepatocellular carcinoma[J]. Cancer Res,2014,74(7):1969-1982. [22] Chen J, Fan Y, Cui B, et al.HMGN2: An antitumor effector molecule of γδT cells[J]. J Immunother,2018,41(3):118-124. [23] Wang J, Lin C, Li H, et al.Tumor-infiltrating γδT cells predict prognosis and adjuvant chemotherapeutic benefit in patients with gastric cancer[J]. Oncoimmunology,2017, 6(11):e1353858. [24] 刘玲. 观察分析肝硬化及肝癌患者γδT细胞的表达[J]. 临床医药文献电子杂志,2016,3(35):6979. [25] Yi Y, He HW, Wang JX, et al.The functional impairment of HCC-infiltrating gammadelta T cells, partially mediated by regulatory T cells in a TGFbeta- and IL-10-dependent manner[J]. J Hepatol,2013,58(5):977-983. [26] Mangan BA, Dunne MR, O′Reilly VP, et al. Cutting edge: CD1d restriction and Th1/Th2/Th17 cytokine secretion by human Vdelta3 T cells[J]. J Immunol,2013,191(1):30-34. [27] Lalazar G, Preston S, Zigmond E, et al.Glycolipids as immune modulatory tools[J]. Mini Rev Med Chem,2006, 6(11):1249-1253. [28] Harly C, Peyrat MA, Netzer S, et al.Up-regulation of cytolytic functions of human Vδ2-γ T lymphocytes through engagement of ILT2 expressed by tumor target cells[J]. Blood,2011,117(10):2864-2873. [29] Pang YL, Zhang HG, Peng JR, et al.The immunosuppressive tumor microenvironment in hepatocellular carcinoma[J]. Cancer Immunol Immunother,2009,58(6):877-886. [30] Cui J, Wang N, Zhao H, et al.Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma[J]. Int J Cancer,2014,134(2):342-351. |
| [1] | ZHANG Jixiang, XIE Zhihua, LI Wei, JIANG Xiaoqing. Classification of intrahepatic cholangiocarcinoma and hot topics in surgical treatment [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 478-482. |
| [2] | YIN Yanjiang, LUO Zhiwen, CHEN Xiao, ZHANG Yefan, HUANG Zhen, ZHAO Hong, ZHAO Jianjun, LI Zhiyu, ZHOU Jianguo, CAI Jianqiang, BI Xinyu. Relationship between surgical margin and prognosis of patients with intrahepatic cholangiocarcinoma [J]. Journal of Surgery Concepts & Practice, 2022, 27(3): 221-228. |
| [3] | CHEN Congyan, WANG Junqing, CHEN Yongjun. Gut microbiota and mechanism of liver cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(3): 256-260. |
| [4] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 93-94. |
| [5] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 95-99. |
| [6] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 100-106. |
| [7] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 107-112. |
| [8] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 113-118. |
| [9] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 119-122. |
| [10] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 123-127. |
| [11] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 128-130. |
| [12] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 131-133. |
| [13] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 134-138. |
| [14] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 139-144. |
| [15] | ZHANG Xihao, ZHANG Xinyun, CAO Manqing, ZHANG Jinliang, WANG Huaqi, ZHANG Su, FU Zhou, WANG Lu, ZHANG Ti. Both anti-angiogenesis and immunotherapy combined with interventional therapy in treatment of hepatocellular carcinoma: effect of hepatic artery infusion chemotherapy compared with hepatic artery chemoembolization [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 152-157. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
